Risk of cancer in inflammatory bowel diseases: umbrella review and re-analysis of meta-analyses

Posted on May 25, 2022 by Gastroenterology Journal

To summarize the epidemiological evidence and assess the validity of claimed associations of inflammatory bowel diseases (IBD) with overall and site-specific cancer risk.

This entry was posted in News. Bookmark the permalink.